Logo
x

Search

Subscribe Now

AML

Janssen Collaborates with Vor to Develop Engineered Hematopoietic Stem Cell Transplants with Bi-Specific Antibody Therapy to Treat AML

Janssen Collaborates with Vor to Develop Engineered Hematopoietic Stem Cell Transplants with Bi-Specific Antibody Therapy to Treat...

  • July 9, 2021
BMS' Onureg (azacytidine) Receives EC's Approval for as Frontline Oral Maintenance Therapy for Adults with Acute Myeloid Leukemia

BMS' Onureg (azacytidine) Receives EC's Approval for as Frontline Oral Maintenance Therapy for Adults with Acute Myeloid Leukemia

  • June 21, 2021
Seelos' SLS-005 (Trehalose) Receives EC's Orphan Drug Designation to Treat Amyotrophic Lateral Sclerosis

Seelos' SLS-005 (Trehalose) Receives EC's Orphan Drug Designation to Treat Amyotrophic Lateral Sclerosis

  • May 28, 2021
AbbVie's Venclyxto Receives the EC's Approval for Patients with Newly Diagnosed Acute Myeloid Leukemia who are Ineligible for Intensive Chemotherapy

AbbVie's Venclyxto Receives the EC's Approval for Patients with Newly Diagnosed Acute Myeloid Leukemia who are Ineligible for Inte...

  • May 26, 2021
Cellectis Collaborates with Sanofi for Alemtuzumab to be Utilized in CART-Cell Trials

Cellectis Collaborates with Sanofi for Alemtuzumab to be Utilized in CART-Cell Trials

  • May 12, 2021
BMS' Opdivo + Yervoy and Onureg Receive EC's CHMP Positive Opinion for MPM and AML

BMS' Opdivo + Yervoy and Onureg Receive EC's CHMP Positive Opinion for MPM and AML

  • April 23, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.